EXOs derived from patients with EGFR-positive lung adenocarcinoma caused, in recipient cells, vimentin overexpression, extracellular matrix degradation, and activation of PI3K/AKT/mTOR, a well-known pathway involved in the EMT process [100]. Here, EGFR is linked to lung adenocarcinoma.